USPTO serial 99605203
MIRALOCK
Reviewed by CopyMark Law Group
Status 688Notice of Allowance
- Filing date
- Status date
- Registration date
- —
- Examiner
- TORPEY, KATHERINE ANN
- Law office
- INTENT TO USE SECTION
What this means
The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.
Need help with MIRALOCK?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $947*
Plus Government fees of $450
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Brent D. Sokol
Brent D. Sokol Greenberg Traurig, LLP1840 Century Park East, Suite 1900Los Angeles, CA 90067United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical substances, chemical materials and chemical preparations for scientific purposes; Active pharmaceutical ingredients, namely, antibodies, proteins and small molecules for use in the manufacture of pharmaceuticals, biopharmaceuticals, vaccines, and finished drug products for the diagnosis, prevention, or treatment of inflammation and immunology disorders or diseases, autoimmune diseases, cancer, and other diseases of the immune systems, digestive systems, skin, joint, lung, liver, kidney, bile duct, nervous systems, or gastrointestinal systems; Antibodies for use in the manufacture of active ingredients of pharmaceuticals and vaccines | ACTIVE | — |
| 005 | Pharmaceutical preparations for the diagnosis, prevention, or treatment of inflammation and immunology disorders or diseases, autoimmune diseases, cancer, and other diseases of the immune systems, digestive systems, skin, joint, lung, liver, kidney, bile duct, nervous systems, or gastrointestinal systems; Diagnostic preparations for medical purposes; Diagnostic kits consisting primarily of monoclonal antibodies for use in disease testing; Chemical, biological and biochemical reagents for medical or veterinary purposes; Diagnostic test kits comprised of medical diagnostic reagents and assays that test for the presence of antigens, pathogens, biomarkers for diseases, or biomarkers for predicting patients' response to therapeutic agents | ACTIVE | — |
| 042 | Research, development and consultation related thereto in the medical, pharmaceutical research and biotechnology fields; Pharmaceutical research and development of pharmaceutical preparations; Research and development services in the fields of human and animal pharmaceutical and biotechnology drug development and manufacture; Laboratory research services in connection with developing new medicinal products; Scientific research, development and consultation services in the fields of immunology, antibodies, vaccines, medicine, biotherapeutics, and therapeutics | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Mirador Therapeutics, Inc.
- Other trademarks owned by Mirador Therapeutics, Inc.
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 042
- Similar marks named MIRALOCK
- Prosecution event NOAM explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 11, 2026 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jun 16, 2026 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jun 16, 2026 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 10, 2026 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| May 19, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 18, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| May 9, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 2, 2026 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Apr 2, 2026 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Apr 2, 2026 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Jan 20, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jan 20, 2026 | NWAP | NEW APPLICATION ENTERED | — |